A comprehensive view of Tandem Diabetes Care Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Tandem Diabetes Care begins widespread US launch of Mobi, its smallest automated insulin delivery system for Type 1 diabetes, compatible with Dexcom's G6 CGM; rollout comes after success in the limited release phase
Published:
February 13, 2024
by FierceBiotech
|
Abbott and Tandem Diabetes Care unveil wireless integration of Abbott's FreeStyle Libre 2 Plus continuous glucose monitor with Tandem's t:slim X2 insulin pump; US diabetes market forecast to grow to US$11.6B by 2025: GlobalData
Published:
January 09, 2024
by MarketLine
|
Baird: Early data suggest GLP-1 weight-loss drugs like Ozempic can drive type-2 diabetes into remission; if fewer patients need an insulin pump to put insulin into the body, companies like Tandem Diabetes Care and Insulet could be hit hard
Published:
October 18, 2023
by Business Insider
|
Tandem Diabetes Care plans late 2023 launch of slimmed-down X2 insulin pump system; system includes Dexcom G7 continuous glucose monitor sensor and Abbott FreeStyle Libre 2 and 3 integrations
Published:
May 04, 2023
by FierceBiotech
|
Ask us about our Tissue & Hygiene market view